KENDRA MAXEY: Open Payments
NPI 1285411603 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 103 payments from 19 companies in 2025. Trend: 2023 $418 · 2024 $1,477 · 2025 $1,729
Food & beverage: $1,729
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $253 |
| PFIZER INC. | 18 | $240 |
| ABBVIE INC. | 12 | $208 |
| Novo Nordisk Inc | 10 | $204 |
| Otsuka America Pharmaceutical, Inc. | 15 | $170 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Amgen Inc. | 5 | $94 |
| Exact Sciences Corporation | 4 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Lundbeck LLC | 3 | $63 |
Products named: REXULTI, NURTEC ODT, MOUNJARO, JARDIANCE, Rybelsus, TRELEGY ELLIPTA, UBRELVY, QULIPTA.
Industry payments across MO — which companies pay providers there.
